“... the total levels of interleukin (IL)‑1α, ‑1β, ‑6, ‑10 and tumour necrosis factor (TNF)‑α in gingival...”
Access document (1)
Access document (2)

“... response was observed after LPS treatment and the addition of RESV led to decreases in expression of the...”
Access document

Access document

Access document

Access document

“...The objective of this study is to investigate the participation of inflammatory and oxidative...”
Access document (1)
Access document (2)

“... given 1, 3, and 5 mg/kg/day of telmisartan orally for 3 days before induction of UC. The same doses were...”
Access document

“...Ischemia and reperfusion injury (IRI) contributes to the development of chronic interstitial...”
Access document (1)
Access document (2)

Subjects: “...Decrease...”
Access document

Subjects: “...Decrease...”
Access document

“... a decrease in the chemoattractant capacity of fibroblasts and in their proinflammatory status. Furthermore...”
Access document (1)
Access document (2)

“... of IL-6, IFN-. TLR7, TLR9, VDR, CYP27b1 and CYP24a1 by flow cytometry. We observed a reduction in the...”
Access document (1)
Access document (2)

“... of Rheumatology. After being stimulated with phorbol 12-myristate 13-acetate and ionomycin in the absence...”
Access document

“... oligodeoxynucleotide (CpG ODNs), and CD40 ligand (CD40L) can decrease ligature-induced periodontal inflammation and...”
Access document

“... oligodeoxynucleotide (CpG ODNs), and CD40 ligand (CD40L) can decrease ligature-induced periodontal inflammation and...”
Access document

“... which plays a central role in host defense and in the acute inflammatory response related to tissue...”
Access document

“...Periodontitis is very prevalent worldwide and is one of the major causes of tooth loss in adults...”
Access document

“... which plays a central role in host defense and in the acute inflammatory response related to tissue...”
Access document (1)
Access document (2)

“...-inflammatory, and microbicidal actions. Intragingival application of GSNO was already shown to decrease...”
Access document

“... NF-κB signaling and patient survival. The efficacy of cisplatin plus the NF-κB inhibitor...”
Access document (1)
Access document (2)